Geoffrey Riggs - OrganiGram Holdings Chief Officer
| OGI Stock | CAD 1.99 0.11 5.85% |
Executive
Geoffrey Riggs is Chief Officer of OrganiGram Holdings
| Address | 145 King Street West, Toronto, ON, Canada, M5H 1J8 |
| Phone | 844 644 4726 |
| Web | https://www.organigram.ca |
OrganiGram Holdings Management Efficiency
The company has return on total asset (ROA) of (0.0148) % which means that it has lost $0.0148 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0464 %, meaning that it generated $0.0464 on every $100 dollars invested by stockholders. OrganiGram Holdings' management efficiency ratios could be used to measure how well OrganiGram Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of February 2026, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.09. At this time, OrganiGram Holdings' Total Assets are very stable compared to the past year. As of the 20th of February 2026, Non Current Assets Total is likely to grow to about 334.9 M, while Non Currrent Assets Other are likely to drop about 4.1 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Neil Belot | Aurora Cannabis | N/A | |
| Judy Hong | Canopy Growth Corp | 53 | |
| Kerry Miller | Aurora Cannabis | N/A | |
| Diane Gajewczyk | Cipher Pharmaceuticals | N/A | |
| Jonathan Page | Aurora Cannabis | 56 | |
| Blake MD | Medical Facilities | N/A | |
| Jenny Brewer | Canopy Growth Corp | N/A | |
| Mark Ware | Canopy Growth Corp | N/A | |
| Dave Mason | HLS Therapeutics | N/A | |
| Bryan Murphy | Canopy Growth Corp | N/A | |
| Dave Aird | Aurora Cannabis | N/A | |
| Keith Stauffer | TerrAscend Corp | 55 | |
| Christiana MBA | Fennec Pharmaceuticals | N/A | |
| Brian Fowler | Medical Facilities | N/A | |
| Travis Wong | Auxly Cannabis Group | N/A | |
| James Rolfe | Medical Facilities | N/A | |
| Vladimir Klacar | Auxly Cannabis Group | 37 | |
| Carla Nawrocki | Auxly Cannabis Group | N/A | |
| David Wheeler | TerrAscend Corp | N/A | |
| Jeroen Beijer | TerrAscend Corp | N/A | |
| Andrew MacMillan | Auxly Cannabis Group | N/A | |
Management Performance
| Return On Equity | 0.0464 | ||||
| Return On Asset | -0.0148 |
OrganiGram Holdings Leadership Team
Elected by the shareholders, the OrganiGram Holdings' board of directors comprises two types of representatives: OrganiGram Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OrganiGram. The board's role is to monitor OrganiGram Holdings' management team and ensure that shareholders' interests are well served. OrganiGram Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OrganiGram Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Helen Martin, Senior Vice President, Strategic, Legal Affairs Corporate Secretary | ||
| Katrina McFadden, Chief Officer | ||
| Megan McCrae, Senior Communications | ||
| Amy Schwalm, Vice President of Investor Relations | ||
| Matthew Rogers, Vice President - Operations | ||
| CFA CA, Chief Officer | ||
| Julie Chamberlain, Vice President of Marketing | ||
| Dexter John, Independent Director | ||
| Peter CMA, Director Finance | ||
| Max Schwartz, Director Relations | ||
| Jeffrey Purcell, Senior Vice President - Operations Services | ||
| Geoffrey Riggs, Chief Officer | ||
| Derrick West, Chief Financial Officer | ||
| CPA CPA, Chief Officer | ||
| Beena Goldenberg, Chief Officer | ||
| Raymond Gracewood, Senior Vice President of Marketing and Communications | ||
| Borna Zlamalik, Senior Innovation | ||
| Paolo Luca, Chief Financial Officer | ||
| Tina Shannon, VP HR | ||
| Peter Amirault, Independent Chairman of the Board | ||
| Nathalie Batten, Senior Operations | ||
| Timothy Emberg, Senior Vice President - Sales and Commercial Operations | ||
| Gregory Engel, Chief Executive Officer, Director | ||
| Nathalie Kubrick, Executive Operations | ||
| Cameron Bishop, Vice President of Public Affairs and Stakeholder Relations | ||
| James Yamanaka, CEO Director | ||
| Geoff Riggs, Chief Officer | ||
| Sherry Porter, Independent Director | ||
| Bradley Gunter, Senior Sales |
OrganiGram Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OrganiGram Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0464 | ||||
| Return On Asset | -0.0148 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 235.21 M | ||||
| Shares Outstanding | 135.14 M | ||||
| Shares Owned By Insiders | 30.16 % | ||||
| Shares Owned By Institutions | 8.91 % | ||||
| Number Of Shares Shorted | 1.16 M | ||||
| Price To Book | 0.64 X |
Pair Trading with OrganiGram Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OrganiGram Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will appreciate offsetting losses from the drop in the long position's value.Moving against OrganiGram Stock
| 0.71 | AMGN | Amgen CDR | PairCorr |
| 0.7 | IPO | InPlay Oil Corp | PairCorr |
| 0.64 | BTE | Baytex Energy Corp | PairCorr |
| 0.64 | BCE | BCE Inc | PairCorr |
| 0.61 | TVE | Tamarack Valley Energy Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to OrganiGram Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OrganiGram Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OrganiGram Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OrganiGram Holdings to buy it.
The correlation of OrganiGram Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OrganiGram Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OrganiGram Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OrganiGram Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.